MicroPort Scientific SEHK 853 Loss Narrows To US$46.6 Million Challenging Bearish Narratives

Simply Wall St.04-02

MicroPort Scientific (SEHK:853) has just posted its FY 2025 first half scorecard, with revenue of US$547.5 million and a basic EPS loss of US$0.03, while trailing twelve month figures show revenue of ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2624504078?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2026-04-02 20:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2624504078","market":"sg","top_or_hot":-1,"title":"MicroPort Scientific SEHK 853 Loss Narrows To US$46.6 Million Challenging Bearish Narratives","media":"Simply Wall St.","content":"<div>\n<p>MicroPort Scientific (SEHK:853) has just posted its FY 2025 first half scorecard, with revenue of US$547.5 million and a basic EPS loss of US$0.03, while trailing twelve month figures show revenue of ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-853/microport-scientific-shares/news/microport-scientific-sehk-853-loss-narrows-to-us466-million\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MicroPort Scientific SEHK 853 Loss Narrows To US$46.6 Million Challenging Bearish Narratives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicroPort Scientific SEHK 853 Loss Narrows To US$46.6 Million Challenging Bearish Narratives\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-02 20:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/healthcare/hkg-853/microport-scientific-shares/news/microport-scientific-sehk-853-loss-narrows-to-us466-million><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MicroPort Scientific (SEHK:853) has just posted its FY 2025 first half scorecard, with revenue of US$547.5 million and a basic EPS loss of US$0.03, while trailing twelve month figures show revenue of ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-853/microport-scientific-shares/news/microport-scientific-sehk-853-loss-narrows-to-us466-million\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1585","symbol_name":"昨日强势股","start_time":0,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-853/microport-scientific-shares/news/microport-scientific-sehk-853-loss-narrows-to-us466-million","article_id":"2624504078","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-853/microport-scientific-shares/news/microport-scientific-sehk-853-loss-narrows-to-us466-million","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2624504078","pubTimestamp":1775132808,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"MicroPort Scientific (SEHK:853) has just posted its FY 2025 first half scorecard, with revenue of US$547.5 million and a basic EPS loss of US$0.03, while trailing twelve month figures show revenue of about US$1.0 billion against a net loss of US$163.8 million and basic EPS of US$0.09 in losses. Over recent periods the company has seen revenue shift between US$558.7 million in 1H 2024, US$472.4 million in 2H 2024 and US$547.5 million in 1H 2025. Basic EPS moved from a loss of US$0.05 in 1H...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1585":"昨日强势股","00853":"微创医疗","BK1583":"高瓴概念","BK1589":"北水核心资产","BK1100":"医疗保健设备"},"translate_title":"微创科技SEHK 853亏损收窄至4660万美元挑战看跌叙事","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00853":0.9},"content_text":"MicroPort Scientific (SEHK:853) has just posted its FY 2025 first half scorecard, with revenue of US$547.5 million and a basic EPS loss of US$0.03, while trailing twelve month figures show revenue of about US$1.0 billion against a net loss of US$163.8 million and basic EPS of US$0.09 in losses. Over recent periods the company has seen revenue shift between US$558.7 million in 1H 2024, US$472.4 million in 2H 2024 and US$547.5 million in 1H 2025. Basic EPS moved from a loss of US$0.05 in 1H 2024 to US$0.06 in 2H 2024 and US$0.03 in 1H 2025, setting up a results season where investors are watching how much of the top line is flowing through to the bottom line and what that implies for margins. See our full analysis for MicroPort Scientific. With the headline numbers on the table, the next step is to see how they line up with the stories investors already tell about MicroPort Scientific, highlighting where the prevailing narratives match the data and where they start to crack. Curious how numbers become stories that shape markets? Explore Community Narratives SEHK:853 Earnings & Revenue History as at Apr 2026 AdvertisementNet losses shrink to US$46.6 million in 1H 2025  Net income excluding extra items was a loss of US$46.6 million in 1H 2025, compared with losses of US$96.8 million in 1H 2024 and US$117.2 million in 2H 2024, while trailing twelve month losses sit at US$163.8 million against just over US$1.0b of revenue. Bears point to earnings declining about 3.1% per year over five years. However, the recent shift from a trailing twelve month loss of US$214.0 million in 2H 2024 to US$163.8 million now challenges the idea that losses are only getting worse, even though the business is still firmly unprofitable.  Revenue around US$1.0b but profits still missing  On a trailing twelve month basis, revenue is US$1,019.9 million against a net loss of US$163.8 million. Across the last three half year periods, sales stayed in a fairly tight band between US$472.4 million and US$558.7 million while each period still produced a loss. What stands out for a bearish view is that, despite revenue forecast growth of about 14.7% per year, the trailing twelve month loss of US$163.8 million and a five year record of deepening losses line up with the concern that higher sales alone have not yet translated into positive earnings. Bears can therefore point to the gap between strong top line figures and continuing negative net income as support for their caution.  On these numbers, skeptics focus on whether revenue growth can meaningfully change the earnings story or if losses stay embedded, and that tension is central to the current debate about MicroPort Scientific's trajectory. 📊 Read the what the Community is saying about MicroPort Scientific. P/S of 2.2x and price below DCF fair value  The stock trades on a P/S of 2.2x compared with peer and industry averages of 5.3x and 4.4x. The current share price of HK$9.17 sits below a DCF fair value estimate of HK$14.62, which is also under the single analyst price target of HK$15.77. Supporters looking for valuation upside often highlight the lower P/S multiple and the gap between HK$9.17 and the DCF fair value of HK$14.62. Those points are consistent with the view in the data that revenue is forecast to grow about 14.7% per year, so a bullish stance leans on the combination of below peer multiples and higher growth expectations, even while accepting that the company currently produces a trailing twelve month loss of US$163.8 million.  Next Steps Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on MicroPort Scientific's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move. With sentiment clearly split between improving losses and ongoing unprofitability, it makes sense to review the numbers yourself and decide how compelling the story really is. To help weigh both sides, take a closer look at the company's 3 key rewards and 1 important warning sign See What Else Is Out There MicroPort Scientific still reports net losses despite around US$1.0b in trailing revenue, so profitability remains a key weakness even though the valuation appears appealing. If you want companies where strong fundamentals already show up more clearly in the numbers, check out the solid balance sheet and fundamentals stocks screener (382 results) to find ideas that may better match your risk comfort.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2624504078","isCrawlerRequest":true}